safe harbor locus in differentiated hematopoietic cells and that a comparison of different promoters is necessary to achieve optimal transgene expression for therapeutic application of iPSC-derived cells.
No takes yet. Share an insight, caveat, or question.
Klatt et al. (2019) studied this question.